BioSpace News Archive

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present at the B. Riley Securities Virtual Annual Oncology Investor Conference on Thursday, January 19, 2023 at 2:30 p.m. ET.

Allogene Therapeutics, Inc. announced that it will participate in two upcoming investor conferences.

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”) and its majority-owned subsidiaries Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or “Lucid Diagnostics”) today provided a strategic business update, outlining near-term strategic priorities and resource reallocation.

Applied BioMath (www.appliedbiomath.com) today announced their participation at the Molecular Glue Drug Development Summit occurring January 24-26, 2023 in Boston, MA.